Literature DB >> 4514982

Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone.

R Burgus, N Ling, M Butcher, R Guillemin.   

Abstract

Somatostatin, a peptide isolated from ovine hypothalamic tissue that inhibits the release of radioimmunoassayable growth hormone in vitro from rat or human pituitary cells or in vivo in rats, has the primary structure [Formula: see text]. The structure was established by submitting the carboxymethylated peptide, the carboxymethylated tryptic digest, and the chymotryptic digest of the peptide to Edman degradation. Degradation products were analyzed by amino-acid analysis, as well as in some cases by determination of N-termini by dansylation or by determination of phenylthiohydantoins by mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4514982      PMCID: PMC433335          DOI: 10.1073/pnas.70.3.684

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  INHIBITION OF CHYMOTRYPSIN ACTIVITY IN CRYSTALLINE TRYPSIN PREPARATIONS.

Authors:  V KOSTKA; F H CARPENTER
Journal:  J Biol Chem       Date:  1964-06       Impact factor: 5.157

2.  Studies on the reduction and re-formation of protein disulfide bonds.

Authors:  C B ANFINSEN; E HABER
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

4.  The use of mass spectrometry in deducing the sequence of somatostatin--a hypothalamic polypeptide that inhibits the secretion of growth hormone.

Authors:  N Ling; R Burgus; J Rivier; W Vale; P Brazeau
Journal:  Biochem Biophys Res Commun       Date:  1973-01-04       Impact factor: 3.575

5.  Quantitative protein sequencing using mass spectrometry: mass spectral analysis of 2-anilino-5-thiazolinone derivatives of amino acids without prior conversion to the phenyl thiohydantoins.

Authors:  T Fairwell; R E Lovins
Journal:  Biochem Biophys Res Commun       Date:  1971-06-18       Impact factor: 3.575

6.  Hydrolysis of proteins with p-toluenesulfonic acid. Determination of tryptophan.

Authors:  T Y Liu; Y H Chang
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

7.  High recovery of tryptophan from acid hydrolysates of proteins.

Authors:  H Matsubara; R M Sasaki
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

8.  The stability of cysteine and cystine during acid hydrolysis of proteins and peptides.

Authors:  A S Inglis; T Y Liu
Journal:  J Biol Chem       Date:  1970-01-10       Impact factor: 5.157

9.  Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin.

Authors:  M Amoss; R Burgus; R Blackwell; W Vale; R Fellows; R Guillemin
Journal:  Biochem Biophys Res Commun       Date:  1971-07-02       Impact factor: 3.575

10.  Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation).

Authors:  R Burgus; M Butcher; M Amoss; N Ling; M Monahan; J Rivier; R Fellows; R Blackwell; W Vale; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

View more
  23 in total

1.  Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas.

Authors:  M P Dubois
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Effects of synthetic somatostatin on endotoxin-induced changes of growth hormone, cortisol and insulin in plasma, blood sugar and blood leukocytes in man.

Authors:  H Wagner; E Zierden; W H Hauss
Journal:  Klin Wochenschr       Date:  1975-06-01

3.  Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity.

Authors:  N Ling; R Burgus; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

4.  Theoretical analysis of somatostatin receptor 5 with antagonists and agonists for the treatment of neuroendocrine tumors.

Authors:  Santhosh Kumar Nagarajan; Sathya Babu; Thirumurthy Madhavan
Journal:  Mol Divers       Date:  2017-02-02       Impact factor: 2.943

5.  Chronic injection of pansomatostatin agonist ODT8-SST differentially modulates food intake and decreases body weight gain in lean and diet-induced obese rats.

Authors:  Andreas Stengel; Tamer Coskun; Miriam Goebel-Stengel; Libbey S Craft; Jorge Alsina-Fernandez; Lixin Wang; Jean Rivier; Yvette Taché
Journal:  Regul Pept       Date:  2011-02-17

Review 6.  Novel neuropeptides as ligands of orphan G protein-coupled receptors.

Authors:  Yan Zhang; Zhiwei Wang; Gregory Scott Parks; Olivier Civelli
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

7.  Processing of an anglerfish somatostatin precursor to a hydroxylysine-containing somatostatin 28.

Authors:  J Spiess; B D Noe
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  Isolation and characterization of somatostatin from pigeon pancreas.

Authors:  J Spiess; J E Rivier; J A Rodkey; C D Bennett; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

9.  Immunohistochemical detection of growth hormone-release inhibiting hormone (somatostatin) in the guinea-pig brain.

Authors:  D Dubé; R Leclerc; G Pelletier; A V Arimura Aschally
Journal:  Cell Tissue Res       Date:  1975-08-25       Impact factor: 5.249

Review 10.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.